RESUMEN
OBJETIVO: Determinar frecuencia, serotipos y susceptibilidad a ocho antimicrobianos en Streptococcus pneumoniae aislados de la nasofaringe de una muestra representativa de niños menores de cinco años de edad residentes en el Distrito Federal. MATERIAL Y MÉTODOS: Estudio transversal, hecho de febrero de 2002 a enero de 2003. Se incluyeron niños de 2 meses a 5 años. A los seleccionados se les tomó una muestra de exudado faríngeo con hisopo de alginato de calcio. Bajo técnicas ya establecidas se realizó identificación, tipificación y susceptibilidad a ocho antimicrobianos de los aislamientos de S. pneumoniae. Se utilizó estadística descriptiva, prueba de Ji cuadrada y razón de momios (IC 95 por ciento) para los factores de riesgo. RESULTADOS: Se estudiaron 573 niños. En 122/573 (21.4 por ciento) niños se aisló S. pneumoniae. Los serotipos más frecuentes fueron el 23F, 35, 19F, 11A y 15A; 46 por ciento de los serotipos encontrados no son cubiertos con la vacuna heptavalente. Se encontró 12 por ciento de susceptibilidad reducida a la penicilina, con 3 por ciento de cepas con alta resistencia; la resistencia a eritromicina fue >30 por ciento y para trimetoprim-sulfametoxazol (TMP/SMX) >40 por ciento. No hubo cepas resistentes a vancomicina, cefotaxima, amoxicilina-clavulanato, cloranfenicol o ampicilina. CONCLUSIONES: El porcentaje de serotipos de S. pneumoniae en portadores nasofaríngeos no cubiertos por la vacuna heptavalente es alto, y la resistencia a macrólidos y TMP/SMX es elevada, lo que debe alertar al grupo médico.
Asunto(s)
Preescolar , Femenino , Humanos , Masculino , Antibacterianos/farmacología , Nasofaringe/microbiología , Streptococcus pneumoniae/clasificación , Streptococcus pneumoniae/efectos de los fármacos , Factores de Edad , Estudios Transversales , Farmacorresistencia Bacteriana , México , Pruebas de Sensibilidad Microbiana , Prevalencia , Serotipificación , Streptococcus pneumoniae/aislamiento & purificaciónRESUMEN
BACKGROUND: Pseudomonas aeruginosa is a common cause of nosocomial infections, particularly in intensive care units (ICUs). The aim of this study was to characterize P. aeruginosa clinical isolates by comparing antimicrobial susceptibility patterns with the presence of plasmids and to establish the clonal relatedness by pulsed-field gel electrophoresis (PFGE) typing. METHODS: The patients included those with isolation of P. aeruginosa hospitalized for more than 48 h in the ICU from April to May 1998. Environmental and staff cultures were obtained simultaneously. Minimal inhibitory concentrations, plasmid DNA profiles, and PFGE genomic patterns of enzyme restriction chromosomal DNA were compared. RESULTS: Sixty P. aeruginosa isolates were obtained from 197 clinical specimens, 178 environmental samples, and 47 hand cultures of personnel. Antimicrobial resistance was as follows: tobramycin 100%; ticarcillin, cefotaxime, ceftriaxone, ceftazidime, and gentamicin 80%; cefepime 60%; amikacin, ticarcillin/clavulanate, imipenem, and meropenem 40%; piperacillin and norfloxacin 20%; carbenicillin 12%, and ciprofloxacin 0%. Plasmids were detected in 11 isolates (18%). PFGE typing showed that 23 isolates belonged to a common clone (pattern A), identified from five patients, two nurses, and 10 environmental samples. Ten isolates were grouped in four clusters and 27 isolates had unrelated genomic patterns. There was no relationship among DNA genomic patterns, plasmid profiles, and susceptibility patterns. CONCLUSIONS: PFGE demonstrated the existence of a common clone in a critical care area. Reinforcement of infection control measures is needed to avoid horizontal transmission and severe infections.
Asunto(s)
Enfermedad Crítica , Infección Hospitalaria/epidemiología , Reservorios de Enfermedades , Infecciones por Pseudomonas/epidemiología , Infección Hospitalaria/complicaciones , Infección Hospitalaria/microbiología , ADN Bacteriano , Farmacorresistencia Microbiana , Electroforesis en Gel de Campo Pulsado , Humanos , Plásmidos , Infecciones por Pseudomonas/complicaciones , Infecciones por Pseudomonas/microbiología , Pseudomonas aeruginosa/efectos de los fármacos , Pseudomonas aeruginosa/genética , Pseudomonas aeruginosa/aislamiento & purificaciónRESUMEN
UNLABELLED: Congenital rubella syndrome (CRS) has been considered an uncommon problem in Mexico. OBJECTIVE: To analyze and describe clinical features of CRS cases in infants from a pediatric hospital in Mexico City during an 8 year period. DESIGN: retrospective study. Patients younger than 18 months of age with a positive serologic test for IgG and IgM rubella antibodies were included. Antibodies were measured by an immunoenzymatic microparticles assay. RESULTS: Fifty-six cases were identified, 42 complete clinical records were available for review. Of these, 23 (54.7%) were female and 19 (45.3%) male. Median for age was five months. A total of 9/42 mothers (21%) had history of rash during pregnancy. IgM antibodies were detected in 15 infants and IgG in 27. Major manifestations were ocular (74%), neurologic (66%), and congenital heart disease (67%). Congenital cataracts were detected in 69%, in 52% hepatomegaly, in 43% jaundice, in 40% anemia, in 48% thrombocytopenia, and hearing loss 19%. CONCLUSION: Five confirmed cases with CRS per year in one hospital indicate a high frequency. Only a small percentage of women had a history of rash during pregnancy. CRS must be investigated in infants with ocular, neurologic, and congenital heart diseases.
Asunto(s)
Síndrome de Rubéola Congénita/diagnóstico , Femenino , Hospitales Pediátricos , Humanos , Lactante , Masculino , México , Estudios RetrospectivosRESUMEN
OBJECTIVE: To determine the prevalence of upper respiratory tract colonization by Moraxella catarrhalis in children under six years of age. MATERIAL AND METHODS: A survey was conducted between January and December 1998 in Mexico City, among children aged 2 months to 5 years, selected through cluster sampling. Pharyngeal samples were taken for M. catarrhalis identification. The minimal inhibitory concentration to different antibiotics was obtained and beta-lactamases were determined by the iodometric test. Statistical analysis consisted of frequency distributions, odds ratios, 95% confidence intervals, and Mantel-Haenszel chi 2. Statistical significance was set at p < 0.05. RESULTS: After excluding 37 children, the study population was 604 children from Mexico City; M. catarrhalis was present in 130 pharyngeal specimens (22.9%). Most of the strains were positive for beta-lactamase production (75.4%). Eighty percent of the strains was resistant to penicillin and 70% to ampicillin and amoxicillin. None were resistant to cefotaxime, imipenem, meropenem and erythromycin. CONCLUSIONS: Prevalence of M. catarrhalis upper respiratory tract colonization is similar to that of other respiratory pathogens. These findings warrant future research on the role of M. catarrhalis as an etiologic agent in acute and chronic respiratory infections in Mexico.
Asunto(s)
Portador Sano/epidemiología , Moraxella catarrhalis/aislamiento & purificación , Infecciones por Neisseriaceae/epidemiología , Distribución por Edad , Portador Sano/microbiología , Preescolar , Intervalos de Confianza , Estudios Transversales , Femenino , Humanos , Lactante , Masculino , México/epidemiología , Pruebas de Sensibilidad Microbiana , Moraxella catarrhalis/efectos de los fármacos , Infecciones por Neisseriaceae/microbiología , Prevalencia , Distribución por SexoRESUMEN
UNLABELLED: Cryptosporidium parvum is associated with diarrheic disease and mainly affects children and immunocompromised hosts. In most of the cases, cryptosporidiosis infection is asymptomatic in immunocompetent subjects. The objectives of the study were to determine the frequency of asymptomatic infection caused by the parasite in children with and without malnutrition and to determine the risk factors associated to infection. METHODS: Children from one to fifteen years old without diarrhea were included, somatometry were performed. The socioeconomic and sanitary conditions were investigated for each family and community. The Faust method and Kinyoun stain were employed identify parasites and Cryptosporidium parvum in feces. Odds ratio (OR), 95% confidence intervals (75% CI), chi 2 Mantel-Haenszel, Fisher exact test and chi 2 trends were calculated. RESULTS: One hundred thirty two children were included. In 10/132 (7.5%) cysts of Cryptosporidium were found, 7/71 in children with malnutrition (9.8%) and 3/61 without malnutrition (4.9%) p = 0.23. 69.7% of the children had parasitosis. According to the presence of C. parvum in feces, the different factors calculated were: Diarrhea in family OR = 5.82 (95%IC 0.86-39.18), not hand washing OR = 5.08 (95%IC 0.62-110.49), age less than 5 years old OR = 4.90 (95%IC 0.60-106.9), drinking non-potable water OR = 3.34 (95%IC 0.40-73.01) and malnutrition 2.11 (95%IC 0.46-10.89). Association was found between the number of people in the same house and the risk of infection (p = 0.005). The presence of diarrhea in the family (OR = 4.15, 95%IC 0.47-36.91) and drinking non-potable water (OR = 4.19, 95%IC 0.48-36.32) were the significant factors in the regression logistic model. CONCLUSIONS: The frequency of Cryptosporidium infection were 7.5%. Diarrhea in the family, overcrowding and drinking non-potable water were associated with C. parvum infection, malnutrition was not a significant risk factor.
Asunto(s)
Criptosporidiosis/complicaciones , Trastornos Nutricionales/complicaciones , Animales , Niño , Preescolar , Criptosporidiosis/epidemiología , Cryptosporidium parvum , Diarrea Infantil/complicaciones , Femenino , Humanos , Lactante , Masculino , México , Población RuralRESUMEN
OBJECTIVE: To describe the results of an epidemiologic surveillance program, from 1990 to the first semester of 1997, in a new high-specialty pediatric hospital and perform a comparison with previous reports. MATERIAL AND METHODS: The total number and type of nosocomial infections, the incidence rate and density incidence for department and division, for different age groups and according to immune statues were registered. RESULTS: The global incidence of nosocomial infections during the period was 25.7 per 100 discharges, with a progressive decrease during the last three years. Although immunocompromised patients had more infections than immunocompetent ones, the difference was not significative. The three most common infections were: pneumonia, vascular line infections and upper respiratory tract infections. It is possible that upper respiratory tract infections are contributing to the elevation of global incidence rates of nosocomial infections. CONCLUSIONS: The change of infection epidemiology regarding previous experience has led to the implementation of programs to prevent the most frequent problems. It is necessary to intensify the different prevention programs and to increase their reach in order to cut down costs in a short term.
Asunto(s)
Infección Hospitalaria/epidemiología , Adolescente , Factores de Edad , Niño , Preescolar , Estudios de Cohortes , Hospitales con 100 a 299 Camas , Hospitales Pediátricos , Humanos , Lactante , Recién Nacido , México/epidemiologíaRESUMEN
OBJECTIVE: To analyze an outbreak of Serratia marcescens in a neonatal intensive care unit and identify the risk factors associated to the development of infection. MATERIAL AND METHODS: It was a case-control study from March to July 1995. Factors included were age, sex, intravascular devices, nebulizers, mechanical ventilation, use of total parenteral nutrition (TPN), underlying diseases, surgical interventions, tubes, previous antimicrobial treatment and days of exposure. The associations were explored using the odds ratio. RESULTS: 24 cases and 30 controls were included. In the univariate analysis the significant risk factors (OR,IC) were use of central venous catheter (4.57, 1.01-23.5), days of use of TPN (4.38, 1.03-16.5), days of previous antimicrobial treatment (4.87, 1.60-22) and days of exposure (2.7, 2.65-27.6). In the multivariate analysis the significant risk factors were previous antimicrobial treatment (3.98, 2.36-18.2), days of previous antimicrobial treatment (6.76, 3.02-24.6) and days of use of TPN (4.87, 1.67-15.6). CONCLUSIONS: The significant risk factors in our study were previous antimicrobial treatment, days of antimicrobial and days of use of TPN.
Asunto(s)
Bacteriemia/epidemiología , Brotes de Enfermedades , Unidades de Cuidado Intensivo Neonatal , Infecciones por Serratia/epidemiología , Serratia marcescens , Antibacterianos/uso terapéutico , Bacteriemia/microbiología , Estudios de Casos y Controles , Cateterismo Venoso Central , Femenino , Humanos , Huésped Inmunocomprometido , Recién Nacido , Masculino , México/epidemiología , Análisis Multivariante , Nebulizadores y Vaporizadores , Oportunidad Relativa , Nutrición Parenteral Total , Prevalencia , Respiración Artificial , Factores de RiesgoRESUMEN
The aim of this study was to evaluate the utility of a volume-modified blood culture system to diagnose bacteremia in newborns and infants. A total of 793 paired blood cultures, obtained from 464 patients (173 newborns and 291 infants), were analyzed. Vacutainer tubes containing 18 ml supplemented peptone broth sodium-polyanethol-sulfonate were used as the gold standard, in comparison with a blood micro-culture system containing 1.8 ml of the broth. Prior to antibiotic treatment, 2.2 ml of blood was obtained from each patient; 0.2 ml was inoculated in a blood micro-culture tube and 2 ml in a routine tube. Sensitivity, specificity and predictive values were calculated. Microorganisms were isolated in 153 standard blood culture tubes and 151 blood micro-culture tubes. The sensitivity of the blood micro-culture system was 95%, specificity 99% and positive and negative predictive values 96% and 99% respectively. The sensitivity and specificity of blood micro-culture in neonates and infants is high. We recommend that this system be used for the diagnosis of bacteremia in newborns and infants in laboratories where manual systems are still in use.
Asunto(s)
Bacteriemia/diagnóstico , Técnicas Bacteriológicas , Bacteriemia/sangre , Técnicas de Tipificación Bacteriana , Sangre/microbiología , Recolección de Muestras de Sangre , Medios de Cultivo , Humanos , Lactante , Recién Nacido , Sensibilidad y EspecificidadAsunto(s)
Antibacterianos/farmacología , Bacterias/efectos de los fármacos , Intestinos/microbiología , Sistema Respiratorio/microbiología , Adulto , Ampicilina/farmacología , Resistencia a la Ampicilina , Animales , Campylobacter jejuni/efectos de los fármacos , Preescolar , Clostridioides difficile/efectos de los fármacos , Diarrea/microbiología , Farmacorresistencia Microbiana , Resistencia a Múltiples Medicamentos , Escherichia coli/efectos de los fármacos , Haemophilus influenzae/efectos de los fármacos , Humanos , Lactante , Resistencia a las Penicilinas , Penicilinas/farmacología , Salmonella typhi/efectos de los fármacos , Salmonella typhimurium/efectos de los fármacos , Shigella/efectos de los fármacos , Shigella dysenteriae/efectos de los fármacos , Streptococcus pneumoniae/efectos de los fármacos , Streptococcus pyogenes/efectos de los fármacos , Vibrio cholerae/efectos de los fármacosRESUMEN
Due to the changes in the frequency of penicillin-resistant strains of S. pneumoniae, it is necessary to perform surveillance studies of bacterial resistance. Isolates from the upper respiratory tract of asymptomatic children have been useful. There is no information about the difference between isolates from children with and without upper respiratory tract infection (URTI). The objective of the authors in this paper is to establish the prevalence of carrier-state, serotype and antimicrobial resistance of S. pneumoniae isolates from children with and without acute upper respiratory tract infection (URTI) in a rural area in Mexico. A cross-sectional comparative study was performed in Tlaxcala, Mexico. Children from one month 5 years of age were included. Nasopharyngeal swabs were obtained. Identification was done by international microbiology standards. Serotyping was done by the capsular Quellung test. The susceptibility testing was performed by the agar dilution method. Four-hundred and fifty patients were included. S. pneumoniae was isolated in 134 children (29.7%). Frequency of carriers was greater in patients with URTI (107/323) than without URTI (27/127) (33.1% vs. 21.1% p = 0.012, OR 1.84, IC 95% 1.1-3.08). The six most frequent serotypes were: 6B (16.4%); 19F (11.9%); 19A (6.7%); 14, 23F, and 35 (5.2% each), with no difference among the groups. Only 3% of the strains had high level resistance to penicillin, and 12.6% had intermediate resistance, and for ampicillin 4%, amoxicillin 4%, amoxicillin-clavulanate 4%, ceftriaxone 3%, cefotaxime 1.5%, erythromycin 6%, miocamycin 3%, chloramphenicol 4%, and vancomycin 0%. Trimethoprim-sulfamethoxazole resistance was very high (42%). In conclusion, colonization is higher in children with URTI. Five of the most frequent serotypes identified in this study were the same as those identified in patients with S. pneumoniae invasive diseases in Mexico City. In Tlaxcala, Mexico, beta-lactams could be the drug of choice for the treatment of S. pneumoniae lower respiratory tract infections. It is necessary to perform clinical assays to evaluate the efficacy of trimethoprim-sulfamethoxazole due to the high resistance in vitro.
Asunto(s)
Antibacterianos/farmacología , Nasofaringe/microbiología , Resistencia a las Penicilinas , Infecciones Neumocócicas/microbiología , Infecciones del Sistema Respiratorio/microbiología , Población Rural , Streptococcus pneumoniae/efectos de los fármacos , Combinación Trimetoprim y Sulfametoxazol/farmacología , Preescolar , Estudios Transversales , Humanos , Lactante , Pruebas de Sensibilidad MicrobianaRESUMEN
A randomized clinical trial was performed in children with cancer, fever and neutropenia, to evaluate the efficacy of amikacin once daily versus thrice daily dosing plus carbenicillin in both groups. Fifty patients were included, 25 patients in group A who received amikacin once daily and 25 in group B who received amikacin thrice daily. No intergroup differences were observed, i.e., fever diminished in a median of 6 days (2-8 days) vs. 7 days (3-12 days) in groups A and B respectively (p = 0.37);clinical improvement was observed in a median of 6 days (3-10 days) vs 7 days (2-14 days) (p = 0.68). One patient in group A and two in B died. The peak levels of amikacin on the 7th day of treatment were 10-60 and 7-25 micrograms/mL in groups A and B respectively, and the serum creatinine levels were 0.3 - 0.7 for group A and 0.2 - 0.8 mg/dL for group B; none of the patients presented a creatinine above 40% of the basal value. Three patients of group A had amikacin levels higher than 40 micrograms/mL without increasing the creatinine levels; our observations do not suggest that toxicity is higher. We conclude that the administration of aminoglycoside once daily seems to be as effective as the traditional dosing.
Asunto(s)
Amicacina/uso terapéutico , Antibacterianos/uso terapéutico , Infecciones Bacterianas/tratamiento farmacológico , Fiebre/tratamiento farmacológico , Neutropenia/complicaciones , Infecciones Bacterianas/etiología , Niño , Preescolar , Esquema de Medicación , Femenino , Fiebre/etiología , Humanos , Huésped Inmunocomprometido , Masculino , Resultado del TratamientoRESUMEN
Objetivo: Se realizó un estudio retrospectivo para estimar la frecuencia de septicemia por Pseudomonas aeruginosa y pseudomonas sp en el Hospital de Pediatría CMN IMSS, así como evaluar la respuesta clínica a los tratamientos actualmente utilizados. Sujetos y métodos: Se incluyeron todos los pacientes con aislamiento de Pseudomonas en hemocultivo en el periodo comprendido entre octubre de 1990 y abril de 1992. Resultados: Se diagnosticó un total de 15 pacientes. Unicamente 12 recibieron tratamiento. El esquema empírico utilizando en pacientes con fiebre y neutropenia sin foco infeccioso identificado fue carbenicilina-amikacina, que se indicó en 7 pacientes. Seis de doce pacientes que recibieron tratamiento fallecimiento se asoció con un tratamiento antimicrobiano inadecuado y en los otros tres hubo falla terapéutica al tratamiento empírico, sólo una de las cepas aisladas de estos tres pacientes era sensible o medianamente sensible a uno o ambos antimicrobianos utilizados, 5 cepas fueron resistentes a carbenicilina, 4 a amikacina, 8 a gentamicina, 10 a cefotaxima, 3 resistentes a ceftazidima y 2 resistentes a imipenem/cilastatín. Conclusiones: La elevada mortalidad que sigue presentándose en relación con la infección por estos gérmenes no obliga a considerar otras opciones terapéuticas. Se sugiere el uso de ceftazidima-amikacina cuando se tenga certeza bacteriológica y el cambio a imipenem-cilastatín/amikacina si la cepa es resistente o no hay respuesta al tratamiento inicial. No se recomienda la monoterapia
Asunto(s)
Humanos , Pruebas de Sensibilidad Microbiana , Pseudomonas/patogenicidad , Sepsis/epidemiología , Infección Hospitalaria/epidemiología , Infección Hospitalaria/microbiología , Infecciones por Pseudomonas/microbiología , Infecciones por Pseudomonas/mortalidad , Pseudomonas/aislamiento & purificación , Sepsis/microbiologíaRESUMEN
Visceral leishmaniasis is a rare parasitosis in our country; in a 30 year period only exists the report of five cases, three in the state of Puebla and two in the state of Guerrero. Now it has been identified another two cases in the state of Chiapas. In these patients the common presentation of the disease were fever, hepatosplenomegaly, hypergammaglobulinemia and pancytopenia. The parasite can be found in liver, spleen, lymph nodes and bone marrow macrophages. A definitive diagnosis depends on the demonstration of the parasite in tissue; spleen biopsy is the most useful because it is positive in 98% of the cases, in other tissues the amastigotes are seen in 50-80% of the cases. Negative PAS-stained smears maintains the diagnosis until another more specific method as electronic microscopy or culture is available. Pentavalent antimonial compounds are the drugs of choice and as an alternative or in case of failure amphotericin B can be used.
Asunto(s)
Leishmaniasis Visceral/diagnóstico , Femenino , Humanos , Lactante , Leishmaniasis Visceral/epidemiología , Leishmaniasis Visceral/parasitología , Masculino , México/epidemiologíaRESUMEN
We report a case of a female infant, from Acapulco Guerrero, Mexico. She had been sick for 45 days, with diarrhea and general malaise, fever during the last 20 days; at physical examination she was pale, with abdominal distention and hepatosplenomegaly. She had leukopenia, thrombocytopenia and anemia. The microscopic findings in the bone marrow sample were intracytoplasmic and extracellular bodies. Both bone marrow and blood cultures were positive for Histoplasma capsulatum. Seventy three pediatric cases of diseminated histoplasmosis have been described in the medical literature since 1934 to 1988. It is know that only about 1% of the persons that become infected will develop a diseminated disease.